Inebilizumab, a B cell-depleting anti-CD19 antibody for the treatment of autoimmune neurological diseases: Insights from preclinical studies

Ding Chen, Sandra Gallagher, Nancy L. Monson, Ronald Herbst, Yue Wang

Research output: Contribution to journalReview articlepeer-review

Fingerprint

Dive into the research topics of 'Inebilizumab, a B cell-depleting anti-CD19 antibody for the treatment of autoimmune neurological diseases: Insights from preclinical studies'. Together they form a unique fingerprint.

Medicine & Life Sciences